argenx NV ADR Earnings

The next earnings date for argenx NV ADR is May 7, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of argenx NV ADR Earnings

Report Date	Estimated Earnings Per Share
05/07/2026	$7.16

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

argenx NV ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
02/26/2026	---	$6.79	14.19%
10/30/2025	---	$0	-100.00%
07/15/2025	Before Market	---	---
05/07/2025	Before Market	$2.27	10.64%
02/27/2025	Before Market	$0.71	-58.04%
10/31/2024	Before Market	$1.39	4,533.33%
07/25/2024	Before Market	$0.45	145.92%
05/09/2024	Before Market	$-1.04	-20.93%
02/29/2024	Before Market	$-1.68	1.18%
10/31/2023	Before Market	$-1.25	18.83%
07/27/2023	Before Market	$-1.69	2.31%
05/07/2023	After Market	$-0.71	68.58%
03/02/2023	---	$-0.70	76.11%
10/27/2022	Before Market	$-4.26	-24.93%
07/28/2022	Before Market	$-3.80	21.33%
05/05/2022	After Market	$-4.36	10.47%
03/03/2022	Before Market	$-5.06	-5.20%
10/28/2021	Before Market	$-4.10	7.24%
07/29/2021	Before Market	$1.98	155.31%
05/14/2021	Before Market	$-0.67	74.13%
03/04/2021	Before Market	$-3.53	-33.71%
10/22/2020	Before Market	$-3.39	-41.84%
07/30/2020	Before Market	$-2.86	-22.75%
05/14/2020	Before Market	$-1.87	-8.72%
02/29/2020	Before Market	$-2.37	-71.74%
10/24/2019	Before Market	$-0.66	43.59%
08/01/2019	Before Market	$-1.37	-67.07%
05/09/2019	After Market	$0.17	122.97%
02/28/2019	After Market	$-0.90	-38.46%
10/25/2018	Before Market	$-0.51	25.00%
08/02/2018	Before Market	$-0.07	85.11%
05/09/2018	Before Market	$-0.55	-44.74%
03/01/2018	Before Market	$-0.41	-17.14%
10/26/2017	Before Market	$-0.41	-20.59%
08/24/2017	Before Market	$0.01	102.70%
05/02/2017	After Market	$-0.44	---
03/15/2017	Before Market	$-0.49	---
10/27/2016	---	$-0.26	---

More About argenx NV ADR

Website

https://argenx.com

Country

USA

Full Time Employees

1,863

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART for the treatment of gMG and immune thrombocytopenia (ITP), and VYVGART HYTRULO for the treatment of gMG and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative gMG, ocular myasthenia gravis (MG), primary ITP, grave's disease, myositis, Sjögren's disease, systemic sclerosis, and AMR; empasiprubart for MMN, delayed graft function, and CIDP; and adimanebart for congenital myasthenic syndrome and spinal muscular atrophy. In addition, the company is developing ARGX-213, a neonatal Fc receptor (FcRn)-targeted antibody engineered for half-life extension and sustained IgG reduction; ARGX-124, a FcRn pipeline candidate; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121, which targets immunoglobulin A; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic partnerships and license agreements with Zai Lab to develop and commercialize efgartigimod; Halozyme Therapeutics to its ENHANZE for the prevention and treatment of human diseases; OncoVerity, Inc for cusatuzumab; and AbbVie, Inc. for ARGX-115. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

“argenx NV ADR Earnings” Can Refer to the argenx NV ADR Earnings Date

Some people say “argenx NV ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my argenx NV ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning argenx NV ADR Stock on the Earnings Date

If you own argenx NV ADR stock (ARGX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for argenx NV ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading argenx NV ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More argenx NV ADR Earnings

You can contact us any time if you would like to ask questions about argenx NV ADR earnings or anything else related to the stock market.